全文获取类型
收费全文 | 19979篇 |
免费 | 1453篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 152篇 |
儿科学 | 730篇 |
妇产科学 | 561篇 |
基础医学 | 2511篇 |
口腔科学 | 292篇 |
临床医学 | 3201篇 |
内科学 | 3361篇 |
皮肤病学 | 180篇 |
神经病学 | 1649篇 |
特种医学 | 525篇 |
外国民族医学 | 1篇 |
外科学 | 1711篇 |
综合类 | 647篇 |
一般理论 | 39篇 |
预防医学 | 2883篇 |
眼科学 | 328篇 |
药学 | 1179篇 |
中国医学 | 14篇 |
肿瘤学 | 1508篇 |
出版年
2023年 | 90篇 |
2022年 | 60篇 |
2021年 | 333篇 |
2020年 | 245篇 |
2019年 | 396篇 |
2018年 | 417篇 |
2017年 | 311篇 |
2016年 | 390篇 |
2015年 | 457篇 |
2014年 | 589篇 |
2013年 | 1032篇 |
2012年 | 1375篇 |
2011年 | 1442篇 |
2010年 | 693篇 |
2009年 | 663篇 |
2008年 | 1247篇 |
2007年 | 1392篇 |
2006年 | 1313篇 |
2005年 | 1291篇 |
2004年 | 1277篇 |
2003年 | 1202篇 |
2002年 | 1138篇 |
2001年 | 243篇 |
2000年 | 194篇 |
1999年 | 232篇 |
1998年 | 195篇 |
1997年 | 166篇 |
1996年 | 173篇 |
1995年 | 189篇 |
1994年 | 166篇 |
1993年 | 142篇 |
1992年 | 165篇 |
1991年 | 137篇 |
1990年 | 143篇 |
1989年 | 138篇 |
1988年 | 139篇 |
1987年 | 102篇 |
1986年 | 131篇 |
1985年 | 98篇 |
1984年 | 112篇 |
1983年 | 97篇 |
1982年 | 93篇 |
1981年 | 106篇 |
1980年 | 97篇 |
1979年 | 92篇 |
1978年 | 74篇 |
1977年 | 67篇 |
1976年 | 76篇 |
1975年 | 58篇 |
1974年 | 69篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
The Patient - Patient-Centered Outcomes Research - 相似文献
3.
Virginia Hill Rice Thomas N. Templin Janet K. Harden Elizabeth S. Jenuwine Ibrahim Abdulhamid Adnan Hammad 《The Journal of adolescent health》2019,64(3):333-339
Purpose
The purpose of this study was to determine the prevalence of respiratory and/or physical fitness health problems in adolescent (ages 18–21) water pipe (WP) smokers (with or without cigarette smoking), cigarette-only smokers, and nonsmokers.Methods
A comparative four-group study design was used to recruit a non–probability sample of 153 WP smokers only, 103 cigarette smokers only, and 102 cigarette+WP smokers along with 296 nonsmokers. Our hypothesis was that youth who smoked WPs and/or cigarettes would report more respiratory problems and/or poorer physical fitness than those who did not smoke.Results
The results showed that coughs were significantly associated with smoking in all three of the smoking groups (p < .05). Cigarette-only smokers reported the most adverse outcomes with more wheezing, difficulty breathing, and less ability to exercise without shortness of breath. A dose-response analysis showed similar patterns of adverse health effects for both WP and cigarette smokers. The combined use of both products was not appreciably worse than smoking one product alone. This could be due to cigarette+WP smokers' reporting using less of the respective products when only one product was smoked.Conclusions
Even during the adolescent years, WP and/or cigarette smoking youth experienced reportable negative health effects. 相似文献4.
5.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献6.
7.
8.
Kimberly A. Lackey Ryan M. Pace Janet E. Williams Lars Bode Sharon M. Donovan Kirsi M. Jrvinen Antti E. Seppo Daniel J. Raiten Courtney L. Meehan Mark A. McGuire Michelle K. McGuire 《Maternal & child nutrition》2020,16(4)
The novel coronavirus SARS‐CoV‐2 has emerged as one of the most compelling and concerning public health challenges of our time. To address the myriad issues generated by this pandemic, an interdisciplinary breadth of research, clinical and public health communities has rapidly engaged to collectively find answers and solutions. One area of active inquiry is understanding the mode(s) of SARS‐CoV‐2 transmission. Although respiratory droplets are a known mechanism of transmission, other mechanisms are likely. Of particular importance to global health is the possibility of vertical transmission from infected mothers to infants through breastfeeding or consumption of human milk. However, there is limited published literature related to vertical transmission of any human coronaviruses (including SARS‐CoV‐2) via human milk and/or breastfeeding. Results of the literature search reported here (finalized on 17 April 2020) revealed a single study providing some evidence of vertical transmission of human coronavirus 229E; a single study evaluating presence of SARS‐CoV in human milk (it was negative); and no published data on MERS‐CoV and human milk. We identified 13 studies reporting human milk tested for SARS‐CoV‐2; one study (a non‐peer‐reviewed preprint) detected the virus in one milk sample, and another study detected SARS‐CoV‐2 specific IgG in milk. Importantly, none of the studies on coronaviruses and human milk report validation of their collection and analytical methods for use in human milk. These reports are evaluated here, and their implications related to the possibility of vertical transmission of coronaviruses (in particular, SARS‐CoV‐2) during breastfeeding are discussed. 相似文献
9.
10.
Janet Crane Jackie Manfredo Elisa Boscolo Mara Coyan Clifford Takemoto Maxim Itkin Denise M. Adams Timothy D. Le Cras 《Pediatric blood & cancer》2020,67(9)
Kaposiform lymphangiomatosis (KLA) is a rare, life‐threatening congenital lymphatic malformation. Diagnosis is often delayed due to complex indistinct symptoms. Blood angiopoietin‐2 (ANG2) levels are elevated in KLA and may be useful as a biomarker to monitor disease status. We report a 7‐year‐old male child with easy bruising, inguinal swelling, and consumptive coagulopathy, diagnosed with KLA. A multimodal treatment regimen of prednisone, sirolimus, vincristine, and adjunctive zoledronate was used. Plasma ANG2 levels were highly elevated at diagnosis but decreased during treatment. The patient showed significant clinical improvement over a 38‐month period and normalization of ANG2 levels correlated with resolution of the coagulopathy. 相似文献